Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Effectiveness of restarting lithium treatment after its discontinuation in bipolar I and bipolar II disorders.

Tondo L, Baldessarini RJ, Floris G, Rudas N.

Am J Psychiatry. 1997 Apr;154(4):548-50.

PMID:
9090344
2.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
3.

A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.

Soares-Weiser K, Bravo Vergel Y, Beynon S, Dunn G, Barbieri M, Duffy S, Geddes J, Gilbody S, Palmer S, Woolacott N.

Health Technol Assess. 2007 Oct;11(39):iii-iv, ix-206. Review.

4.

Effects of lithium treatment and its discontinuation on suicidal behavior in bipolar manic-depressive disorders.

Baldessarini RJ, Tondo L, Hennen J.

J Clin Psychiatry. 1999;60 Suppl 2:77-84; discussion 111-6. Review.

5.
6.

Long-term combination therapy versus monotherapy with lithium and carbamazepine in 46 bipolar I patients.

Baethge C, Baldessarini RJ, Mathiske-Schmidt K, Hennen J, Berghöfer A, Müller-Oerlinghausen B, Bschor T, Adli M, Bauer M.

J Clin Psychiatry. 2005 Feb;66(2):174-82. Review.

PMID:
15705002
7.
8.
9.

[Treatment and prevention of mania: lithium and alternatives].

Vestergaard P.

Ugeskr Laeger. 1993 Aug 9;155(32):2438-42. Review. Danish.

PMID:
8102824
10.

Does lithium treatment still work? Evidence of stable responses over three decades.

Baldessarini RJ, Tondo L.

Arch Gen Psychiatry. 2000 Feb;57(2):187-90. Review.

PMID:
10665622
11.

Efficacy of lithium in mania and maintenance therapy of bipolar disorder.

Bowden CL.

J Clin Psychiatry. 2000;61 Suppl 9:35-40. Review.

12.

A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder.

Yatham LN.

J Affect Disord. 2011 Jan;128 Suppl 1:S21-8. doi: 10.1016/S0165-0327(11)70005-2. Review.

PMID:
21220077
13.

Rational polypharmacy in the bipolar affective disorders.

Post RM, Ketter TA, Pazzaglia PJ, Denicoff K, George MS, Callahan A, Leverich G, Frye M.

Epilepsy Res Suppl. 1996;11:153-80. Review.

PMID:
9294735
14.

Polytherapy in bipolar disorder.

Lin D, Mok H, Yatham LN.

CNS Drugs. 2006;20(1):29-42. Review.

PMID:
16396522
15.

Antipsychotics in bipolar disorder.

Gelenberg AJ, Hopkins HS.

J Clin Psychiatry. 1996;57 Suppl 9:49-52. Review.

PMID:
8823350
16.

Lithium and relapse prevention in manic-depressive illness.

Schou M.

Psychosomatics. 1983 Jun;24(6):533-5, 537, 540-1. Review. No abstract available.

PMID:
6136064
17.

Risk of recurrence following discontinuation of lithium treatment in bipolar disorder.

Suppes T, Baldessarini RJ, Faedda GL, Tohen M.

Arch Gen Psychiatry. 1991 Dec;48(12):1082-8. Review.

PMID:
1845226
18.

A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.

Bridle C, Palmer S, Bagnall AM, Darba J, Duffy S, Sculpher M, Riemsma R.

Health Technol Assess. 2004 May;8(19):iii-iv, 1-187. Review.

19.

[Risk of inducing resistance upon stopping and restarting lithium after long-term usage].

Oostervink F, Nolen WA, Hoenderboom AC, Kupka RW.

Ned Tijdschr Geneeskd. 2000 Feb 26;144(9):401-4. Review. Dutch.

PMID:
10719540
20.

Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.

Macritchie KA, Geddes JR, Scott J, Haslam DR, Goodwin GM.

Cochrane Database Syst Rev. 2001;(3):CD003196. Review. Update in: Cochrane Database Syst Rev. 2013;10:CD003196.

PMID:
11687047
Items per page

Supplemental Content

Write to the Help Desk